In a post-hoc analysis of the published SURPASS trials, the change in systolic blood pressure was greater for tirzepatide versus the comparators of the trials (tirzepatide 5 mg: -5.1 to -1.3 mmHg, tirzepatide 10 mg: -6.5 to -1.7 mmHg, tirzepatide 15 mg: -11.5 to -3.1 mmHg) [65]
Prompt recognition and appropriate response to potential gallbladder symptoms can prevent serious complications in patients taking GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists
Evidence from other weight-loss modalities indicates that many patients gradually stop self-monitoring, experience emotional fluctuations, or return to loss-of-control eating behaviors, all of which are associated with increased relapse risk [90]
Jessica advocates for longitudinal care relationships and individualized plans that address hunger cues, sleep, and food environment to prevent weight return
Phase 2: early titration (weeks 5 through 8) Semaglutide dose: 0.5 mg per week This is where most people start feeling real appetite changes
Med 361 , 13761385, (2009)
%25201.png)
